Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Experimental and Therapeutic Medicine|June 20, 2014
Interferon-α enhances the susceptibility of renal cell carcinoma to rapamycin by suppressing mTOR activityXiao Han, Donghao Shang, Tiandong Han, et al.
Cancer Science|June 19, 2007
Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistanceDonghao Shang, Yuting Liu, Noriyuki Ito, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2017
VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinomaDonghao Shang, Shaozhong Xian, Tiandong Han, et al.
Cancer Investigation|May 24, 2011
Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signalingDonghao Shang, Peiqian Yang, Yuting Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 16, 2020
ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genesXuanhao Li, Donghao Shang, Hongliang Shen, et al.
Genes|November 24, 2022
Prognosis Risk Model Based on Necroptosis-Related Signature for Bladder CancerZhenghao Chen, Rui Cao, Ren Wang, et al.
Cancer Investigation|June 5, 2014
Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinomaDonghao Shang, Rumei Bi, Tiandong Han, et al.
Frontiers in Oncology|January 2, 2023
A tumor microenvironment preoperative nomogram for prediction of lymph node metastasis in bladder cancerZhenghao Chen, Chuan Qin, Gang Wang, et al.
European Urology|February 6, 2007
Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activityDonghao Shang, Noriyuki Ito, Jun Watanabe, et al.
Pageof 4